Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.

Dana L CaseyYueh-Yun ChiSarah S DonaldsonDouglas S HawkinsJing TianCarola A ArndtDavid A RodebergJonathan C RouthTimothy B LautzAbha A GuptaTorunn I YockSuzanne L Wolden

Published in: Cancer (2019)

Despite interventions designed to enhance local control, local control was inferior on ARST0531 in comparison with D9803. The reason for this is unclear, but it could be the reduced cyclophosphamide dose on ARST0531.

Keyphrases

young adults
low dose
palliative care
physical activity
high dose